What is SurgiCare?
SurgiCare of Manhattan operates as a highly accredited Ambulatory Surgical Center, distinguishing itself through a commitment to clinical excellence and patient-centric recovery protocols. The facility serves as a critical node in the regional healthcare infrastructure, offering specialized outpatient procedures that eliminate the necessity for overnight hospital stays. With accolades such as the APEX Award and the Gold Seal of Approval from the Joint Commission, the company has established a reputation for operational precision and superior medical outcomes. Their integration of state-of-the-art surgical technology, combined with a world-class team of surgeons and nursing staff, positions them as a leader in the outpatient surgical sector, effectively bridging the gap between traditional hospital settings and specialized private care.
How much funding has SurgiCare raised?
SurgiCare has raised a total of $350K across 1 funding round:
Debt
$350K
Debt (2020): $350K with participation from PPP
Key Investors in SurgiCare
PPP
Public-Private Partnership
What's next for SurgiCare?
With this recent strategic investment, SurgiCare is well-positioned to accelerate its operational scaling and technological integration. The capital will likely be deployed to enhance facility capacity, upgrade existing surgical suites with next-generation instrumentation, and expand the breadth of outpatient services offered to the Manhattan patient base. As the healthcare industry continues to favor cost-effective, high-quality outpatient alternatives, SurgiCare's focus on patient comfort and recovery efficiency provides a sustainable competitive advantage. Future growth trajectories will likely involve optimizing patient throughput and potentially exploring additional regional footprints to meet the rising demand for specialized, non-inpatient surgical solutions.
See full SurgiCare company page
